Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collado-Hidalgo, A.
Right arrow Articles by Irwin, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collado-Hidalgo, A.
Right arrow Articles by Irwin, M. R.
Clinical Cancer Research Vol. 12, 2759-2766, May 1, 2006
© 2006 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Inflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors

Alicia Collado-Hidalgo1, Julienne E. Bower1,2, Patricia A. Ganz2, Steve W. Cole1,3 and Michael R. Irwin1

Authors' Affiliations: 1 Cousins Center for Psychoneuroimmunology, University of California at Los Angeles Semel Institute for Neuroscience and Human Behavior, 2 Division of Cancer Prevention and Control, Jonsson Comprehensive Cancer Center, University of California at Los Angeles School of Medicine and Public Health, and 3 Department of Medicine, David E. Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California

Requests for reprints: Michael R. Irwin, Cousins Center for Psychoneuroimmunology, University of California at Los Angeles Semel Institute for Neuroscience and Human Behavior, 300 Medical Plaza, Room 3109, Los Angeles, CA 90095-7076; E-mail: mirwin1{at}ucla.edu.

Purpose: This study seeks to define immunologic and inflammatory variables associated with persistent post-treatment fatigue in breast cancer survivors.

Experimental Design: Leukocyte subsets, plasma inflammatory markers, and ex vivo proinflammatory cytokine production were assessed in 50 fatigued and nonfatigued breast cancer survivors recruited ≥2 years after successful primary therapy. Multivariate statistical analyses were used to define a composite immunologic biomarker of fatigue risk.

Results: Fatigued breast cancer survivors were distinguished from nonfatigued survivors by increased ex vivo monocyte production of interleukin (IL)-6 and tumor necrosis factor-{alpha} following lipopolysaccharide stimulation, elevated plasma IL-1ra and soluble IL-6 receptor (sIL-6R/CD126), decreased monocyte cell-surface IL-6R, and decreased frequencies of activated T lymphocytes and myeloid dendritic cells in peripheral blood (all P < 0.05). An inverse correlation between sIL-6R and cell-surface IL-6R was consistent with inflammation-mediated shedding of IL-6R, and in vitro studies confirmed that proinflammatory cytokines induced such shedding. Multivariate linear discriminant function analysis identified two immunologic markers, the ratio of sIL-6R to monocyte-associated IL-6R and decreased circulating CD69+ T lymphocytes, as highly diagnostic of fatigue (P = 0.0005), with cross-validation estimates indicating 87% classification accuracy (sensitivity = 0.83; specificity = 0.83).

Conclusion: These results extend links between fatigue and inflammatory markers to show a functional alteration in proinflammatory cytokine response to lipopolysaccharide and define a prognostic biomarker of behavioral fatigue.




This article has been cited by other articles:


Home page
PsychosomaticsHome page
M. R. Levy
Cancer Fatigue: A Neurobiological Review for Psychiatrists
Psychosomatics, July 1, 2008; 49(4): 283 - 291.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
J. Clin. Oncol., February 20, 2008; 26(6): 971 - 982.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. E. Bower
Behavioral Symptoms in Patients With Breast Cancer and Survivors
J. Clin. Oncol., February 10, 2008; 26(5): 768 - 777.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. E. Dimsdale and R. Dantzer
A Biological Substrate for Somatoform Disorders: Importance of Pathophysiology
Psychosom Med, November 1, 2007; 69(9): 850 - 854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M.-F. O'Connor, S. J. Motivala, E. M. Valladares, R. Olmstead, and M. R. Irwin
Sex differences in monocyte expression of IL-6: role of autonomic mechanisms
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R145 - R151.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. R. Fann, C. M. Alfano, S. Roth-Roemer, W. J. Katon, and K. L. Syrjala
Impact of Delirium on Cognition, Distress, and Health-Related Quality of Life After Hematopoietic Stem-Cell Transplantation
J. Clin. Oncol., April 1, 2007; 25(10): 1223 - 1231.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. R. Irwin, L. Olmos, M. Wang, E. M. Valladares, S. J. Motivala, T. Fong, T. Newton, A. Butch, R. Olmstead, and S. W. Cole
Cocaine Dependence and Acute Cocaine Induce Decreases of Monocyte Proinflammatory Cytokine Expression across the Diurnal Period: Autonomic Mechanisms
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. R. Irwin, M. Wang, C. O. Campomayor, A. Collado-Hidalgo, and S. Cole
Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation.
Arch Intern Med, September 18, 2006; 166(16): 1756 - 1762.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.